Mechanisms of HIV receptor and co-receptor down-regulation by prostratin: Role of conventional and novel PKC isoforms

Antiviral Chemistry and Chemotherapy

Volumn 15, Issue 4, 2004, Pages 207-222

  Hezareh, Marjan ^a   Moukil, Moulay Ahmed ^b   Szanto, Ildiko ^b,c   Pondarzewski, Malgorzata ^b   Mouche, Sarah ^b,c   Cherix, Nathalie ^b   Brown, Stephen J ^a   Carpentier, Jean Louis ^b   Foti, Michelangelo ^b  

^a AIDS Research Alliance (ARA)   (United States)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

CD4; CXCR4; HIV; PKC; Prostratin

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ISOPROTEIN; MEMBRANE PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTRATIN; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG RESEARCH; DRUG SCREENING; DRUG SPECIFICITY; ENDOCYTOSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; MONOCYTE; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

EID: 4344651661     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020401500404     Document Type: Article

References (54)

1. Altman A, Isakov N & Baier G (2000) Protein kinase Ctheta: a new essential superstar on the T-cell stage. Immunology Today 21:567-573.
2. Aramori I, Ferguson SS, Bieniasz PD, Zhang J, Cullen B & Cullen MG (1997) Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO Journal 16:4606-4616.
3. Baier G, Baier-Bitterlich G, Meller N, Coggeshall KM, Giampa L, Telford D, Isakov N & Altman A (1994) Expression and biochemical characterization of human protein kinase C-theta. European Journal of Biochemistry 225:195-203.
4. Baier-Bitterlich G, Uberall F, Bauer B, Fresser F, Wachter H, Grunicke H, Utermann G, Altman A & Baier G (1996) Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Molecular & Cellular Biology 16:1842-1850.
5. Bi K & Altman A (2001) Membrane lipid microdomains and the role of PKCtheta in T cell activation. Seminar Immunology 13:139-146.
6. Bocklandt S, Blumberg PM & Hamer DH (2003) Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate. Antiviral Research 59:89-98.
7. Brooks DG, Hamer DH, Arlen PA, Gao L, Bristol G, Kitchen CM, Berger EA & Zack JA (2003) Molecular characterization, reactivation, and depletion of latent HIV. Immunity 19:413-423.
8. Chambers JD, Simon SI, Berger EM, Sklar LA & Arfors KE (1993) Endocytosis of beta 2 integrins by stimulated human neutrophils analyzed by flow cytometry. Journal of Leukocyte Biology 53:462-469.
9. Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, Lloyd AL, Nowak MA & Fauci AS (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proceedings of the National Academy of Sciences, USA 94:13193-13197.
10. Clemens MJ, Trayner I & Menaya J (1992) The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. Journal of Cellular Science 103:881-887.
11. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA & Messing RO (2000) Protein kinase C isozymes and the regulation of diverse cell responses. American Journal of Physiology. Lung Cellular & Molecular Physiology 279:L429-438.
12. Fantoni M, Del Borgo C & Autore C (2003) Evaluation and management of metabolic and coagulative disorders in HIV-infected patients receiving highly active antiretroviral therapy AIDS 17 (Suppl 1):S162-169.
13. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD & Siliciano RF (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
14. Firestein GS, Reifler D, Richman D & Gruber HE (1988) Rapid and reversible modulation of T4 (CD4) on monocytoid cells by phorbol myristate acetate: effect on HIV susceptibility. Cellular Immunology 113:63-69.
15. Folgueira L, McElhinny JA, Bren GD, MacMorran WS, Diaz-Meco MT, Moscat J & Paya CV (1996) Protein kinase C-zeta mediates NF-kappa B activation in human immunodeficiency virus-infected monocytes. Journal of Virology 70:223-231.
16. Garofalo T, Sorice M, Misasi R, Cinque B, Giammatteo M, Pontieri GM, Cifone MG & Pavan A (1998) A novel mechanism of CD4 down-modulation induced by monosialoganglioside GM3. Involvement of serine phosphorylation and protein kinase c delta translocation. Journal of Biological Chemistry 273:35153-35160.
17. Gulakowski RJ, McMahon JB, Buckheit RW Jr, Gustafson KR & Boyd MR (1997) Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV). Antiviral Research 33:87-97.
18. Gustafson KR, Cardellina JH 2nd, McMahon JB, Gulakowski RJ, Ishitoya J, Szallasi Z, Lewin NE, Blumberg PM, Weislow OS, Beutler JA, Buckeit RW Jr, Crag GM, Cox PA, Bader JP & Boyd MR (1992) A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1. Journal of Medicinal Chemistry 35:1978-1986.
19. Haribabu B, Richardson RM, Fisher I, Sozzani S, Peiper SC, Horuk R, Ali H & Snyderman R (1997) Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. Journal of Biological Chemistry 272:28726-28731.
20. Heath KV, Montaner JS, Bondy G, Singer J, O'Shaughnessy MV & Hogg RS (2003) Emerging drug toxicities of highly active anti-retroviral therapy for human immunodeficiency virus (HIV) infection. Current Drug Targets 4:13-22.
21. Isakov N, McMahon P & Altman A (1990) Selective post-transcriptional down-regulation of protein kinase C isoenzymes in leukemic T cells chronically treated with phorbol ester. Journal of Biological Chemistry 265:2091-2097.
22. Kinter AL, Poli G, Maury W, Folks TM & Fauci AS (1990) Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. Journal of Virology 64:4306-4312.
23. Korin YD, Brooks DG, Brown S, Korotzer A & Zack JA (2002) Effects of prostratin on T-cell activation and human immunodeficiency virus latency. Journal of Virology 76:8118-8123.
24. Kulkosky J, Culnan DM, Roman J, Dornadula G, Schnell M, Boyd MR & Pomerantz RJ (2001) Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood 98:3006-3015.
25. Kulkosky J, Nunnari G, Otero M, Calarota S, Dornadula G, Zhang H, Malin A, Sullivan J, Xu Y, DeSimone J, Babinchak T, Stern J, Cavert W, Haase A & Pomerantz RJ (2002) Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy. Journal of Infectious Diseases 186:1403-1411.
26. Laurence J, Sikder SK, Jhaveri S & Salmon JE (1990) Phorbol ester-mediated induction of HIV-1 from a chronically infected promonocyte clone: blockade by protein kinase inhibitors and relationship to tat-directed trans-activation. Biochemical & Biophysical Research Communications 166:349-357.
27. Lin X, O'Mahony A, Mu Y, Geleziunas R & Greene WC (2000) Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta. Molecular & Cellular Biology 20:2933-2940.
28. Liu WS & Heckman CA (1998) The sevenfold way of PKC regulation. Cellular Signalling 10:529-542.
29. Mangasarian A, Foti M, Aiken C, Chin D, Carpentier JL & Trono D (1997) The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. Immunity 6:67-77.
30. Mufson RA, Myers C, Turpin JA & Meltzer M (1992) Phorbol ester reduces constitutive nuclear NF kappa B and inhibits HIV-1 production in mature human monocytic cells. Journal of Leukocyte Biology 52:637-644.
31. Parolini I, Topa S, Sorice M, Pace A, Ceddia P, Montesoro E, Pavan A, Lisanti MP, Peschle C & Sargiacomo M (1999) Phorbol ester-induced disruption of the CD4-Lck complex occurs within a detergent-resistant microdomain of the plasma membrane. Involvement of the translocation of activated protein kinase C isoforms. Journal of Biological Chemistry 274:14176-14187.
32. Pelchen-Matthews A, Armes JE, Griffiths G & Marsh M (1991) Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells. Journal of Experimental Medicine 173:575-587.
33. Pelchen-Matthews A, Armes JE & Marsh M (1989) Internalization and recycling of CD4 transfected into HeLa and NIH3T3 cells. EMBO Journal 8:3641-3649
34. Pelchen-Matthews A, Boulet I, Littman DR, Fagard R & Marsh M (1992) The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits. Journal of Cellular Biology 117:279-290.
35. Pelchen-Matthews A, Parsons IJ & Marsh M (1993) Phorbol ester-induced downregulation of CD4 is a multistep process involving dissociation from p56lck, increased association with clathrin-coated pits, and altered endosomal sorting. Journal of Experimental Medicine 178:1209-1222.
36. Pelchen-Matthews A, Signoret N, Klasse PJ, Fraile-Ramos A & Marsh M (1999) Chemokine receptor trafficking and viral replication. Immunology Review 168:33-49.
37. Rhee SS & Marsh JW (1994) Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. Journal of Virology 68:5156-5163.
38. Roebuck KA, Gu DS & Kagnoff MF (1996) Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression. AIDS 10:819-826.
39. Shin J, Doyle C, Yang Z, Kappes D & Strominger JL (1990) Structural features of the cytoplasmic region of CD4 required for internalization. EMBO Journal 9:425-434.
40. Shoji M, Girard PR, Mazzei GJ, Vogler WR & Kuo JF (1986) Immunocytochemical evidence for phorbol ester-induced protein kinase C translocation in HL60 cells. Biochemical & Biophysical Research Communications 135:1144-1149.
41. Signoret N, Oldridge J, Pelchen-Matthews A, Klasse PJ, Tran T, Brass LF, Rosenkilde MM, Schwartz TW, Holmes W, Dallas W, Luther MA, Wells TN, Hoxie JA & Marsh M (1997) Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. Journal of Cellular Biology 139:651-664.
42. Signoret N, Rosenkilde MM, Klasse PJ, Schwartz TW, Malim MH, Hoxie JA & Marsh M (1998) Differential regulation of CXCR4 and CCR5 endocytosis. Journal of Cell Science 111:2819-2830.
43. Smith BL, Krushelnycky BW, Mochly-Rosen D & Berg P (1996) The HIV nef protein associates with protein kinase C theta. Journal of Biological Chemistry 271:16753-16757.
44. Swanson JA (1989) Phorbol esters stimulate macropinocytosis and solute flow through macrophages. Journal of Cell Science 94:135-142.
45. Szallasi Z & Blumberg PM (1991) Prostratin, a nonpromoting phorbol ester, inhibits induction by phorbol 12-myristate 13-acetate of ornithine decarboxylase, edema, and hyperplasia in CD-1 mouse skin. Cancer Research 51:5355-5360.
46. Szallasi Z, Krausz KW & Blumberg PM (1992) Non-promoting 12-deoxyphorbol 13-esters as potent inhibitors of phorbol 12-myristate 13-acetate-induced acute and chronic biological responses in CD-1 mouse skin. Carcinogenesis 13:2161-2167.
47. Szallasi Z, Krsmanovic L & Blumberg PM (1993) Nonpromoting 12-deoxyphorbol 13-esters inhibit phorbol 12-myristate 13-acetate induced tumor promotion in CD-1 mouse skin. Cancer Research 53:2507-2512.
48. Tsutsumi A, Kubo M, Fujii H, Freire-Moar J, Turck CW & Ransom JT (1993) Regulation of protein kinase C isoform proteins in phorbol ester-stimulated Jurkat T lymphoma cells. Journal of Immunology 150:1746-1754.
49. Ventura C & Maioli M (2001) Protein kinase C control of gene expression. Critical Reviews in Eukaryotic Gene Expression 11:243-267.
50. Willey RL, Maldarelli F, Martin MA & Strebel K (1992) Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. Journal of Virology 66:7193-200.
51. Witvrouw M, Pannecouque C, Fikkert V, Hantson A, Van Remoortel B, Hezareh M, De Clercq E & Brown SJ (2003) Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entry. Antiviral Chemistry & Chemotherapy 14:321-328.
52. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA & Richman DD (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295.
53. Zayed S, Hafez A, Adolf W & Hecker E (1977) New tigliane and daphnane derivatives from Pimeleaprostrata and Pimelea simplex. Experientia 33:1554-1555.
54. Zufferey R, Nagy D, Mandel RJ, Naldini L & Trono D (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnology 15:871-875.